Unlocking the potential of
genomic medicine


Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.  More>>

There are no items to display.

Stock Quote

Recent News

More >>
Date Title and Summary
Toggle Summary02/15/2017
PHILADELPHIA, PA -- (Marketwired) -- 02/15/17 -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced that it will host an Investor Day with senior management and key opinion leaders to discuss AEVI-001 and opportunities in the ADHD market.
Toggle Summary08/10/2017
PHILADELPHIA , Aug. 10, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") today announced the execution of a definitive agreement to sell shares of common stock and warrants to purchase common stock in a private placement, or PIPE, to certain accredited investors, led
Toggle Summary08/21/2018
- Initiation of enrollment in Part B of the ASCEND trial - Top-line data for Parts A and B of ASCEND expected in Q4 2018 PHILADELPHIA , Aug. 21, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced the sale of 5.1 million shares of its common stock for

Recent Presentations

More >>

Upcoming Events

More >>
There are currently no events to display.

Recent Events

More >>
Date Event Details
Summary Toggle 08/13/19 at 1:20 PM EDT

Aevi Genomic Medicine, Inc. at 2019 Wedbush PacGrow Healthcare Conference

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Aevi Genomic Medicine, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Copyright West LLC. Minimum 15 minutes delayed.